BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 1788003)

  • 1. [Vaccinal measles process in children during the manifestations of acute respiratory diseases].
    Sergeeva MV; Vorotyntseva NV; Titova NS
    Pediatriia; 1991; (10):57-61. PubMed ID: 1788003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological reactivity of children vaccinated with a live measles vaccine].
    Bolotovskiĭ VM; Titova NS; Zakharova TR; Vorotyntseva NV; Mushkova EM
    Vopr Virusol; 1983; 28(5):588-90. PubMed ID: 6659474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-immunological characteristics of the measles vaccine process in frequently ill children].
    Lakotkina EA; Zheleznikova GF; Blagoslovenskiĭ GS; Cherniaeva TV; Vozniuk TI
    Pediatriia; 1988; (1):48-51. PubMed ID: 3362610
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immune response of children with an iron deficiency to vaccination with a live measles vaccine].
    Kazakova LM; Makrushin IM; Tsvetova GV; Arsent'eva TN; Shabaldin AV
    Pediatriia; 1992; (7-9):36-7. PubMed ID: 1475138
    [No Abstract]   [Full Text] [Related]  

  • 5. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
    Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and immunological reactions after measles vaccination with cleavage vaccine and live vaccine].
    Stehr K; Enders G; Suschke HJ; Spiess H
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):383-7. PubMed ID: 5523685
    [No Abstract]   [Full Text] [Related]  

  • 9. Sidestepping maternal antibody: a lesson from measles virus vaccination.
    Kim D; Niewiesk S
    Expert Rev Clin Immunol; 2011 Sep; 7(5):557-9. PubMed ID: 21895466
    [No Abstract]   [Full Text] [Related]  

  • 10. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 11. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

  • 12. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 14. [The HLA antigen system and the immune response in measles vaccination].
    Kharit SM; Kapralova MA
    Tr Inst Im Pastera; 1985; 62():72-5. PubMed ID: 3843366
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles virus-specific IgG4 antibody titer as a serologic marker of post-vaccinal immune response.
    Isa MB; Martínez LC; Ferreyra LJ; Giordano MO; Barril PA; Massachessi G; Nates SV
    Viral Immunol; 2006; 19(2):335-9. PubMed ID: 16817776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions].
    Naruszewicz-Lesiuk D; Kańtoch M; Polna I
    Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines.
    Craighead JE
    J Infect Dis; 1975 Jun; 131(6):749-54. PubMed ID: 1169271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities of measles vaccination in children with counterindications and duration of preservation of postvaccinal immunity].
    Piriev GG; Liashchenko VA
    Pediatriia; 1990; (12):27-30. PubMed ID: 2075059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.